<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV), which was first isolated by Epstein, Barr, and Achong (1964) from a cultured Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> lymphoblast cell line, is the etiological agent for <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e> (IM), polyclonal oligoclonal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> associated with primary and acquired <z:hpo ids='HP_0002721'>immunodeficiencies</z:hpo>, and the complications of <z:hpo ids='HP_0001417'>X-linked</z:hpo> lymphoproliferative syndrome (XLP) (Cantani and Mastrantoni, 1989; Englund, 1988; Ernberg et al., 1990; Jones and Straus, 1987; Okano et al., 1988; Purtilo et al., 1981; Shearer et al., 1985; Wilmes and Wolf, 1989) </plain></SENT>
<SENT sid="1" pm="."><plain>EBV also contributes to the pathogenesis of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Frizzera, 1987; Harrington et al., 1988; Henle et al., 1968; Purtilo et al., 1981; Rowe et al., 1986; Saemundsen et al., 1981) and <z:e sem="disease" ids="C0153392" disease_type="Neoplastic Process" abbrv="">nasopharyngeal cancer</z:e> (Pearson et al., 1984) </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, people who have had IM have higher rates of subsequent development of malignant <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> (Abo et at., 1982; Snydman et al., 1982) and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (Green et al., 1979; Mueller, 1987; Poppema et al., 1985; Weiss et al., 1989), while patents with XLP have a higher incidence of non-Hodgkin's malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Harrington et at., 1987) </plain></SENT>
<SENT sid="3" pm="."><plain>The precise role of EBV in these diseases is not well understood </plain></SENT>
<SENT sid="4" pm="."><plain>Nonetheless, it is known that <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> triggers the formation of heterophile antibodies that, for many decades, have formed the basis for serologic diagnosis of IM </plain></SENT>
<SENT sid="5" pm="."><plain>In this review, we discuss the discovery, species variation, and structure of the erythrocyte membrane-associated Paul-Bunnell (PB) heterophile antibody determinant, its implications to IM diagnosis, and its potential contribution to defective immune surveillance and associated uncontrolled proliferation of EBV-infected cells </plain></SENT>
</text></document>